Kayla C. Stanley

East Carolina University, Meredith College

Papers

Total Citations

H-Index

About

Kayla C. Stanley is a researcher focused on advancing minimally invasive techniques for lung cancer treatment, particularly through improved motion management in stereotactic ablative radiotherapy (SABR). Her primary contributions center on enhancing the precision of fiducial marker placement during electromagnetic navigational bronchoscopy (ENB), a critical step for tracking respiratory motion in patients with early-stage non-small cell lung cancer or oligometastatic disease. In her most cited work (2019, 5 citations), she introduced a novel guidance system that significantly improves the accuracy of marker deployment, directly addressing the challenge of continuous tumor movement within the lungs. This innovation helps ensure that SABR—a key alternative for non-surgical candidates—can be delivered with greater reliability, potentially reducing treatment margins and sparing healthy tissue. Her earlier study (2017, 2 citations) laid foundational groundwork for this approach. By tackling a practical bottleneck in lung radiotherapy, Stanley’s research offers tangible benefits for clinical workflows and patient outcomes, making her work valuable for both interventional pulmonologists and radiation oncologists seeking to optimize motion-compensation strategies in thoracic oncology.